1-3 of 3
S Iacobelli
Close
Sort by
Journal Articles

High Levels of Tumor Load Reduction after Intensive Chemotherapy Favorably Affect the Prognosis of BCR/ABL+ ALL Adult Patients Receiving Imatinib Mesylate Alone as a Post-Consolidation Treatment According to the Italian GIMEMA LAL 0201/A Protocol.

G. Cimino, MD, L. Elia, PhD, Fabrizio Pane, MD, M. Vignetti, MD, P. Fazi, MD, S. Iacobelli, PhD, G. Meloni, MD, A. Vitale, MD, V. Martini, MD, G. Martinelli, MD, F. Di Raimondo, MD, M. Bonifacio, MD, F. Fabbiano, MD, G. Saglio, MD, M. Baccarani, MD, R. Foà, MD, F. Mandelli, MD
Journal: Blood
Blood (2006) 108 (11): 638.
https://doi.org/10.1182/blood.V108.11.638.638
Published: 2006
Journal Articles

Prognostic Impact of Genetic Characterization in the GIMEMA LAM99P Study for Newly Diagnosed Adult AML. Relevance of Combined Analysis of Conventional Karyotyping, FLT3 and NPM Mutational Status.

G. Saglio, Francesco Lo Coco, A. Cuneo, F. Pane, G. Rege Cambrin, D. Diverio, M. Mancini, N. Testoni, M. Vignetti, P. Fazi, S. Iacobelli, A. Bardi, B. Izzo, N. Bolli, R. La Starza, S. Amadori, F. Mandelli, P.G. Pelicci, C. Mecucci, B. Falini
Journal: Blood
Blood (2005) 106 (11): 226.
https://doi.org/10.1182/blood.V106.11.226.226
Published: 2005
Journal Articles

Clinical implications of glucocorticoid receptor studies in childhood acute lymphoblastic leukemia

R Mastrangelo, R Malandrino, R Riccardi, P Longo, FO Ranelletti, S Iacobelli
Journal: Blood
Blood (1980) 56 (6): 1036–1040.
https://doi.org/10.1182/blood.V56.6.1036.1036
Published: 1980